In stent restenosis predictors after carotid artery stenting.
Purpose. The long-term efficacy of carotid artery stenting is debated. Predictors of stent restenosis are not fully investigated. Our aim was to assess the incidence of long term restenosis after CAS and to identify some predictors of restenosis. Methods. We retrospectively selected 189 treated patients and we obtained the survival Kaplan-Meier curves for overall survival, for freedom from stroke or death and from restenosis. To correlate clinical, radiological, and procedural variables to stent restenosis, an univariate analysis was performed while to determine independent predictors of restenosis, a multivariate analysis was applied. Results. At 1, 3, and 5 years, the cumulative overall survival rate was 98%, 94%, and 92% with a cumulative primary patency rate of 87%, 82.5%, and 82.5%. The percentage residual stenosis after CAS and multiple stents deployment were independent predictors of restenosis, while diabetes and tumors are suggestive but not significant predictors of restenosis. Conclusions. In our CAS experience, encouraging long-term results seem to derive from both neurological event free rate and restenosis incidence. Adequate recanalization of the treated vessel is important to limit the development of stent restenosis. Multiple stents deployment, and with less evidence, diabetes, or neoplasms has to be considered to facilitate restenosis.
Cosottini
Mirco
M
Department of Neuroscience, University of Pisa, Pisa 56100, Italy.
Michelassi
Maria Chiara
MC
Bencivelli
Walter
W
Lazzarotti
Guido
G
Picchietti
Silvia
S
Orlandi
Giovanni
G
Parenti
Giuliano
G
Puglioli
Michele
M
Circulation. 1998 Feb 10;97(5):501-9
9490248
J Cardiovasc Surg (Torino). 2005 Jun;46(3):241-7
15956921
Radiology. 2003 May;227(2):516-21
12649420
Stroke. 2002 Apr;33(4):1063-70
11935062
J Vasc Surg. 2004 Apr;39(4):728-34
15071433
Heart. 2002 Oct;88(4):381-6
12231597
J Am Coll Cardiol. 2006 Jun 20;47(12):2390-6
16781364
Eur Radiol. 2009 Apr;19(4):982-9
18987863
J Endovasc Ther. 2003 Jun;10(3):636-42
12932179
Diabetologia. 2004 Mar;47(3):400-406
14985968
Diabetes. 1993 Jan;42(1):1-7
8420806
Am J Cardiol. 2001 Aug 1;88(3):253-9
11472703
Eur J Vasc Endovasc Surg. 2005 Jun;29(6):601-7
15878537
J Endovasc Ther. 2002 Jun;9(3):299-307
12096944
Am J Cardiol. 2003 Oct 1;92(7):895-7
14516904
Ann Intern Med. 1993 Mar 1;118(5):344-9
8430980
Lancet. 2001 Jun 2;357(9270):1729-37
11403808
Stroke. 2002 Nov;33(11):2658-63
12411657
J Endovasc Ther. 2002 Feb;9(1):1-13
11958312
Stroke. 1998 Jan;29(1):244-50
9445358
J Cardiovasc Surg (Torino). 2006 Apr;47(2):153-60
16572089
Ann N Y Acad Sci. 2001 Dec;947:271-92; discussion 292-3
11795276
Stroke. 2005 Feb;36(2):367-73
15625299
N Engl J Med. 1991 Aug 15;325(7):445-53
1852179
J Am Coll Cardiol. 1997 Nov 15;30(6):1428-36
9362398
N Engl J Med. 2004 Oct 7;351(15):1493-501
15470212
J Vasc Surg. 2003 Jun;37(6):1234-9
12764270
Eur J Vasc Endovasc Surg. 2003 Aug;26(2):141-4
12917827
J Vasc Surg. 2005 Aug;42(2):213-9
16102616
J Vasc Surg. 1994 May;19(5):818-27; discussion 827-8
8170035
Circulation. 2001 Jan 30;103(4):532-7
11157718
Br Heart J. 1991 Nov;66(5):337-45
1747292
Circulation. 1991 Oct;84(4):1636-43
1914103
Surg Clin North Am. 2004 Oct;84(5):1281-94, vi
15364555
J Endovasc Ther. 2003 Dec;10(6):1031-8
14723573
Circulation. 2006 Jul 4;114(1):e1-4
16818819
Stroke. 2003 Mar;34(3):813-9
12624315
Radiology. 1994 May;191(2):309-12
8153296
J Cardiovasc Surg (Torino). 2008 Dec;49(6):743-7
19043388
J Am Coll Cardiol. 2007 Jan 2;49(1):126-70
17207736
Stroke. 1987 Nov-Dec;18(6):1031-6
3318001